Literature DB >> 19962790

[Comparison of conventional and non-conventional serological tests for the diagnosis of imported Chagas disease in Spain].

María Flores-Chávez1, Israel Cruz, Mercedes Rodríguez, Javier Nieto, Elena Franco, Teresa Gárate, Carmen Cañavate.   

Abstract

INTRODUCTION: Trypanosoma cruzi infection is a major imported parasitic disease in Spain, because of the increase of immigrants from endemic areas. Since the laboratory diagnosis during the chronic phase is based on detection of anti-T. cruzi IgG antibodies, our aims were to compare 10 tests for determining anti-T. cruzi antibodies, to assess their cross-reactivity with related diseases, and to evaluate the rk39-ELISA and IFAT-Leishmania tests as tools for the differential diagnosis of leishmaniasis due to Leishmania infantum.
MATERIAL AND METHODS: A total of 223 sera were tested: 40 had been previously characterized by Qpanel, and 183 were obtained from the serum library of the Parasitology Department, Centro Nacional de Microbiología (66 chagasic, 97 healthy, 30 visceral leishmaniasis, and 30 malaria). Samples were examined using in-house IFAT and ELISA, 5 commercial ELISAs (Certest/Abbot Laboratories/BiosChile; Ortho Clinical Diagnostics; BLK Diagnostic; bioMérieux; and Biokit), particle gel agglutination (ID-PaGIA), and two immunochromatographic assays (Operon and CTK Biotech). The last 4 tests are based in recombinant antigens (non-conventional tests).
RESULTS: The IFAT and ELISAs showed a sensitivity of 97% to 100%. The immunochromatographic tests had somewhat lower sensitivity (92%-96%). All non-conventional tests presented a smaller number of cross-reactions. Leishmania-Rk39-ELISA did not show cross-reactivity with chagasic sera.
CONCLUSIONS: In general, our results confirm the data obtained by other authors. The sensitivity of ELISA is higher than other tests; therefore, these techniques would be the most appropriate for screening of T. cruzi infection. A suitable approach is the combination of a test using total antigen with another based on either recombinant antigens or synthetic peptides. (c) 2009 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19962790     DOI: 10.1016/j.eimc.2009.07.005

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  23 in total

1.  Sensitivity and specificity of an operon immunochromatographic test in serum and whole-blood samples for the diagnosis of Trypanosoma cruzi infection in Spain, an area of nonendemicity.

Authors:  María Flores-Chavez; Israel Cruz; Javier Nieto; Teresa Gárate; Miriam Navarro; Ana Pérez-Ayala; Rogelio López-Vélez; Carmen Cañavate
Journal:  Clin Vaccine Immunol       Date:  2012-07-03

Review 2.  Chagas disease and transfusion medicine: a perspective from non-endemic countries.

Authors:  Andrea Angheben; Lucia Boix; Dora Buonfrate; Federico Gobbi; Zeno Bisoffi; Simonetta Pupella; Giorgio Gandini; Giuseppe Aprili
Journal:  Blood Transfus       Date:  2015-10       Impact factor: 3.443

3.  Serological Diagnosis of Chronic Chagas Disease: Is It Time for a Change?

Authors:  Alba Abras; Montserrat Gállego; Teresa Llovet; Silvia Tebar; Mercedes Herrero; Pere Berenguer; Cristina Ballart; Carmen Martí; Carmen Muñoz
Journal:  J Clin Microbiol       Date:  2016-04-06       Impact factor: 5.948

4.  [Imported Chagas disease: alarm in Europe… as it should be].

Authors:  Ainhoa Irueta Isusi; Mar Jarque Moyano; Patricia Redondo Ruiz; Vanesa Pérez Martin
Journal:  Aten Primaria       Date:  2011-04-15       Impact factor: 1.137

5.  Dried blood as an alternative to plasma or serum for Trypanosoma cruzi IgG detection in screening programs.

Authors:  Africa Holguín; Francesca Norman; Leticia Martín; María Luisa Mateos; Jesús Chacón; Rogelio López-Vélez; José A Pérez-Molina
Journal:  Clin Vaccine Immunol       Date:  2013-06-05

6.  Validation of a rapid immunochromatographic assay for diagnosis of Trypanosoma cruzi infection among Latin-American Migrants in Geneva, Switzerland.

Authors:  François Chappuis; Anne Mauris; Marylise Holst; Pedro Albajar-Vinas; Jean Jannin; Alejandro O Luquetti; Yves Jackson
Journal:  J Clin Microbiol       Date:  2010-06-16       Impact factor: 5.948

7.  Chagas disease screening among HIV-positive Latin American immigrants: an emerging problem.

Authors:  J Llenas-García; A Hernando; S Fiorante; D Maseda; M Matarranz; E Salto; R Rubio; F Pulido
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-01-19       Impact factor: 3.267

8.  Chronic Chagas Disease Diagnosis: A Comparative Performance of Commercial Enzyme Immunoassay Tests.

Authors:  Fred Luciano Neves Santos; Wayner Vieira de Souza; Michelle da Silva Barros; Mineo Nakazawa; Marco Aurélio Krieger; Yara de Miranda Gomes
Journal:  Am J Trop Med Hyg       Date:  2016-03-14       Impact factor: 2.345

9.  Performance of six diagnostic tests to screen for Chagas disease in blood banks andprevalence of Trypanosoma cruzi infection among donors with inconclusive serologyscreening based on the analysis of epidemiological variables.

Authors:  Gilberto de Araujo Pereira; Francisco Louzada-Neto; Valdirene de Fátima Barbosa; Márcia Maria Ferreira-Silva; Helio de Moraes-Souza
Journal:  Rev Bras Hematol Hemoter       Date:  2012

10.  Trypanosoma cruzi infection in Elche (Spain): comparison of the seroprevalence in immigrants from Paraguay and Bolivia.

Authors:  José M Ramos; Yamileth Ponce; Ingrid Gallegos; María Flóres-Chávez; Carmen Cañavate; Félix Gutiérrez
Journal:  Pathog Glob Health       Date:  2012-05       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.